Literature DB >> 1155038

The effect of naftidrofuryl on the metabolic response to exercise in man.

S W Shaw, R H Johnson.   

Abstract

We have designed this investigation to determine whether naftidrofuryl has an effect upon metabolism in vivo in man. Five subjects were studied during and after steady exercise on a bicycle ergometer. On the first occasion they received naftidrofuryl (300 mg orally) 20-40 min before exercise; and on the second they exercised without the drug to provide control observations. Blood samples were taken for the estimation of glucose, pyruvate, lactate, glycerol, acetoacetate and 3-hydroxybutyrate. Exercise with naftidrofuryl caused a significantly greater rise in blood pyruvate concentration during the exercise and post-exercise period compared with the controls. Changes in glucose, lactate, glycerol and ketone-bodies were not significantly different from the control values. Lactate/pyruvate ratios were significantly reduced with naftidrofuryl during the post-exercise period. Exercise causes a rise in intracellular anaerobic metabolism with associated increases in blood lactate/pyruvate ratios. This is followed by enhanced oxidative capacity during the recovery period as adduced from falling lactate/pyruvate ratios. The greater decline in lactate/pyruvate ratios with naftidrofuryl during the post-exercise period is evidence that naftidrofuryl is able to enhance cellular oxidative activity in vivo in man. Further studies in clinical situations are therefore indicated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155038     DOI: 10.1111/j.1600-0404.1975.tb05777.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  11 in total

1.  Can drug therapy alter the natural course of peripheral vascular disease?: a review.

Authors:  C A Clyne
Journal:  Proc R Soc Med       Date:  1977

Review 2.  Naftidrofuryl: a review of its use in the treatment of intermittent claudication.

Authors:  David R Goldsmith; Keri Wellington
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Pharmacological approaches to the treatment of intermittent claudication.

Authors:  E G Bevan; P C Waller; L E Ramsay
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

Review 4.  Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.

Authors:  L B Barradell; R N Brogden
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

5.  Effects of naftidrofuryl on microcirculatory cold sensitivity in Raynaud's phenomenon.

Authors:  K H Nilsen
Journal:  Br Med J       Date:  1979-01-06

Review 6.  'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.

Authors:  A Spagnoli; G Tognoni
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

7.  Effect of naftidrofuryl on the metabolic response to surgery.

Authors:  H J Burns; D J Galloway; I M Ledingham
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-04

8.  The effect of naftidrofuryl oxalate on cerebral blood flow in elderly patients.

Authors:  I M James; P Newbury; M L Woolard
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

9.  New approach to treatment of recent stroke.

Authors:  A K Admani
Journal:  Br Med J       Date:  1978-12-16

10.  Effects of naftidrofuryl on breathlessness and exercise tolerance in chronic bronchitis.

Authors:  A J Williams; J Osman; C Skinner
Journal:  Thorax       Date:  1982-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.